Skip to main content
NewslettersWatchlist
hello world

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Merus Announces Financial Results for the First Quarter 2022 and Provides Business Update

Globe Newswire - Mon May 9, 2022

- Zenocutuzumab clinical abstract selected for oral presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
-Company to host investor call on Sunday, June 5 at 6:00 p.m. CT
- Clinical data update of petosemtamab (Peto) and MCLA-129 planned for second half of 2022

Read more at globenewswire.com

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).